nodes	percent_of_prediction	percent_of_DWPC	metapath
Protriptyline—Tongue discolouration—Temozolomide—malignant glioma	0.0417	0.0494	CcSEcCtD
Protriptyline—Extrapyramidal disorder—Temozolomide—malignant glioma	0.0267	0.0317	CcSEcCtD
Protriptyline—Petechiae—Temozolomide—malignant glioma	0.0245	0.029	CcSEcCtD
Protriptyline—Coordination abnormal—Carmustine—malignant glioma	0.0212	0.0251	CcSEcCtD
Protriptyline—Coordination abnormal—Temozolomide—malignant glioma	0.0205	0.0243	CcSEcCtD
Protriptyline—Gynaecomastia—Carmustine—malignant glioma	0.0186	0.0221	CcSEcCtD
Protriptyline—Vascular purpura—Temozolomide—malignant glioma	0.0163	0.0194	CcSEcCtD
Protriptyline—Purpura—Temozolomide—malignant glioma	0.0152	0.018	CcSEcCtD
Protriptyline—Ataxia—Carmustine—malignant glioma	0.0142	0.0169	CcSEcCtD
Protriptyline—Ataxia—Temozolomide—malignant glioma	0.0137	0.0163	CcSEcCtD
Protriptyline—Pancytopenia—Carmustine—malignant glioma	0.0124	0.0147	CcSEcCtD
Protriptyline—Duloxetine—SLC6A3—malignant glioma	0.0123	0.177	CrCbGaD
Protriptyline—Pancytopenia—Temozolomide—malignant glioma	0.012	0.0142	CcSEcCtD
Protriptyline—Pollakiuria—Temozolomide—malignant glioma	0.0117	0.0138	CcSEcCtD
Protriptyline—Erectile dysfunction—Temozolomide—malignant glioma	0.0116	0.0138	CcSEcCtD
Protriptyline—Weight increased—Temozolomide—malignant glioma	0.0115	0.0136	CcSEcCtD
Protriptyline—Neuropathy peripheral—Carmustine—malignant glioma	0.0114	0.0135	CcSEcCtD
Protriptyline—Stomatitis—Carmustine—malignant glioma	0.0114	0.0135	CcSEcCtD
Protriptyline—Neuropathy peripheral—Temozolomide—malignant glioma	0.011	0.0131	CcSEcCtD
Protriptyline—Stomatitis—Temozolomide—malignant glioma	0.011	0.013	CcSEcCtD
Protriptyline—Hypoaesthesia—Carmustine—malignant glioma	0.0104	0.0123	CcSEcCtD
Protriptyline—Hallucination—Carmustine—malignant glioma	0.0104	0.0123	CcSEcCtD
Protriptyline—Hallucination—Temozolomide—malignant glioma	0.0101	0.0119	CcSEcCtD
Protriptyline—Hypoaesthesia—Temozolomide—malignant glioma	0.0101	0.0119	CcSEcCtD
Protriptyline—Flushing—Carmustine—malignant glioma	0.00971	0.0115	CcSEcCtD
Protriptyline—Tinnitus—Temozolomide—malignant glioma	0.00943	0.0112	CcSEcCtD
Protriptyline—Flushing—Temozolomide—malignant glioma	0.00938	0.0111	CcSEcCtD
Protriptyline—Maprotiline—SLC6A3—malignant glioma	0.00938	0.135	CrCbGaD
Protriptyline—Arrhythmia—Carmustine—malignant glioma	0.00935	0.0111	CcSEcCtD
Protriptyline—Alopecia—Carmustine—malignant glioma	0.00925	0.011	CcSEcCtD
Protriptyline—Alopecia—Temozolomide—malignant glioma	0.00894	0.0106	CcSEcCtD
Protriptyline—Dysgeusia—Temozolomide—malignant glioma	0.00862	0.0102	CcSEcCtD
Protriptyline—Vision blurred—Carmustine—malignant glioma	0.00858	0.0102	CcSEcCtD
Protriptyline—Tremor—Carmustine—malignant glioma	0.00853	0.0101	CcSEcCtD
Protriptyline—Agitation—Carmustine—malignant glioma	0.00837	0.00992	CcSEcCtD
Protriptyline—Vision blurred—Temozolomide—malignant glioma	0.0083	0.00983	CcSEcCtD
Protriptyline—Tremor—Temozolomide—malignant glioma	0.00825	0.00977	CcSEcCtD
Protriptyline—Ill-defined disorder—Temozolomide—malignant glioma	0.00817	0.00968	CcSEcCtD
Protriptyline—Leukopenia—Carmustine—malignant glioma	0.00815	0.00966	CcSEcCtD
Protriptyline—Agitation—Temozolomide—malignant glioma	0.00809	0.00959	CcSEcCtD
Protriptyline—Carbamazepine—CYP2B6—malignant glioma	0.00803	0.115	CrCbGaD
Protriptyline—Malaise—Temozolomide—malignant glioma	0.00794	0.00941	CcSEcCtD
Protriptyline—Convulsion—Carmustine—malignant glioma	0.00789	0.00935	CcSEcCtD
Protriptyline—Leukopenia—Temozolomide—malignant glioma	0.00788	0.00934	CcSEcCtD
Protriptyline—Hypertension—Carmustine—malignant glioma	0.00786	0.00932	CcSEcCtD
Protriptyline—Palpitations—Temozolomide—malignant glioma	0.00778	0.00922	CcSEcCtD
Protriptyline—Anxiety—Carmustine—malignant glioma	0.00773	0.00916	CcSEcCtD
Protriptyline—Convulsion—Temozolomide—malignant glioma	0.00763	0.00904	CcSEcCtD
Protriptyline—Hypertension—Temozolomide—malignant glioma	0.0076	0.00901	CcSEcCtD
Protriptyline—Confusional state—Carmustine—malignant glioma	0.0075	0.00888	CcSEcCtD
Protriptyline—Anxiety—Temozolomide—malignant glioma	0.00747	0.00885	CcSEcCtD
Protriptyline—Oedema—Carmustine—malignant glioma	0.00743	0.00881	CcSEcCtD
Protriptyline—Discomfort—Temozolomide—malignant glioma	0.0074	0.00877	CcSEcCtD
Protriptyline—Phenylbutazone—PTGS1—malignant glioma	0.00739	0.106	CrCbGaD
Protriptyline—Desipramine—CYP2C18—malignant glioma	0.00733	0.105	CrCbGaD
Protriptyline—Dry mouth—Temozolomide—malignant glioma	0.00733	0.00868	CcSEcCtD
Protriptyline—Thrombocytopenia—Carmustine—malignant glioma	0.00728	0.00862	CcSEcCtD
Protriptyline—Tachycardia—Carmustine—malignant glioma	0.00726	0.0086	CcSEcCtD
Protriptyline—Confusional state—Temozolomide—malignant glioma	0.00724	0.00858	CcSEcCtD
Protriptyline—Oedema—Temozolomide—malignant glioma	0.00718	0.00851	CcSEcCtD
Protriptyline—Anorexia—Carmustine—malignant glioma	0.00709	0.0084	CcSEcCtD
Protriptyline—Thrombocytopenia—Temozolomide—malignant glioma	0.00703	0.00833	CcSEcCtD
Protriptyline—Hypotension—Carmustine—malignant glioma	0.00695	0.00823	CcSEcCtD
Protriptyline—Anorexia—Temozolomide—malignant glioma	0.00685	0.00811	CcSEcCtD
Protriptyline—Insomnia—Carmustine—malignant glioma	0.00672	0.00797	CcSEcCtD
Protriptyline—Paraesthesia—Carmustine—malignant glioma	0.00668	0.00791	CcSEcCtD
Protriptyline—Somnolence—Carmustine—malignant glioma	0.00661	0.00783	CcSEcCtD
Protriptyline—Insomnia—Temozolomide—malignant glioma	0.0065	0.0077	CcSEcCtD
Protriptyline—Decreased appetite—Carmustine—malignant glioma	0.00646	0.00766	CcSEcCtD
Protriptyline—Paraesthesia—Temozolomide—malignant glioma	0.00645	0.00764	CcSEcCtD
Protriptyline—Atomoxetine—SLC6A3—malignant glioma	0.00645	0.0927	CrCbGaD
Protriptyline—Somnolence—Temozolomide—malignant glioma	0.00639	0.00757	CcSEcCtD
Protriptyline—Constipation—Carmustine—malignant glioma	0.00636	0.00753	CcSEcCtD
Protriptyline—Dyspepsia—Temozolomide—malignant glioma	0.00632	0.00749	CcSEcCtD
Protriptyline—Decreased appetite—Temozolomide—malignant glioma	0.00625	0.0074	CcSEcCtD
Protriptyline—Fatigue—Temozolomide—malignant glioma	0.00619	0.00734	CcSEcCtD
Protriptyline—Constipation—Temozolomide—malignant glioma	0.00614	0.00728	CcSEcCtD
Protriptyline—Feeling abnormal—Carmustine—malignant glioma	0.00613	0.00726	CcSEcCtD
Protriptyline—Feeling abnormal—Temozolomide—malignant glioma	0.00592	0.00702	CcSEcCtD
Protriptyline—Body temperature increased—Carmustine—malignant glioma	0.00588	0.00696	CcSEcCtD
Protriptyline—Abdominal pain—Carmustine—malignant glioma	0.00588	0.00696	CcSEcCtD
Protriptyline—Urticaria—Temozolomide—malignant glioma	0.00571	0.00676	CcSEcCtD
Protriptyline—Abdominal pain—Temozolomide—malignant glioma	0.00568	0.00673	CcSEcCtD
Protriptyline—Body temperature increased—Temozolomide—malignant glioma	0.00568	0.00673	CcSEcCtD
Protriptyline—Desipramine—CYP2B6—malignant glioma	0.00544	0.0783	CrCbGaD
Protriptyline—Asthenia—Carmustine—malignant glioma	0.00533	0.00632	CcSEcCtD
Protriptyline—SLC6A4—Synaptic Vesicle Pathway—SYP—malignant glioma	0.00527	0.0609	CbGpPWpGaD
Protriptyline—Asthenia—Temozolomide—malignant glioma	0.00515	0.00611	CcSEcCtD
Protriptyline—Diarrhoea—Carmustine—malignant glioma	0.00509	0.00603	CcSEcCtD
Protriptyline—Pruritus—Temozolomide—malignant glioma	0.00508	0.00602	CcSEcCtD
Protriptyline—Dizziness—Carmustine—malignant glioma	0.00492	0.00583	CcSEcCtD
Protriptyline—Diarrhoea—Temozolomide—malignant glioma	0.00492	0.00582	CcSEcCtD
Protriptyline—Dizziness—Temozolomide—malignant glioma	0.00475	0.00563	CcSEcCtD
Protriptyline—Vomiting—Carmustine—malignant glioma	0.00473	0.0056	CcSEcCtD
Protriptyline—Rash—Carmustine—malignant glioma	0.00469	0.00555	CcSEcCtD
Protriptyline—Dermatitis—Carmustine—malignant glioma	0.00468	0.00555	CcSEcCtD
Protriptyline—Headache—Carmustine—malignant glioma	0.00466	0.00552	CcSEcCtD
Protriptyline—Desipramine—SLC6A3—malignant glioma	0.00464	0.0667	CrCbGaD
Protriptyline—Vomiting—Temozolomide—malignant glioma	0.00457	0.00541	CcSEcCtD
Protriptyline—Rash—Temozolomide—malignant glioma	0.00453	0.00537	CcSEcCtD
Protriptyline—Dermatitis—Temozolomide—malignant glioma	0.00453	0.00536	CcSEcCtD
Protriptyline—Headache—Temozolomide—malignant glioma	0.0045	0.00533	CcSEcCtD
Protriptyline—Nausea—Carmustine—malignant glioma	0.00442	0.00523	CcSEcCtD
Protriptyline—Nortriptyline—PTGS1—malignant glioma	0.00435	0.0625	CrCbGaD
Protriptyline—Nausea—Temozolomide—malignant glioma	0.00427	0.00506	CcSEcCtD
Protriptyline—Phenylbutazone—PTGS2—malignant glioma	0.00423	0.0607	CrCbGaD
Protriptyline—CYP2D6—CYP2E1 reactions—CYP2B6—malignant glioma	0.00346	0.04	CbGpPWpGaD
Protriptyline—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—malignant glioma	0.0031	0.0358	CbGpPWpGaD
Protriptyline—CYP2D6—Fatty acids—CYP2B6—malignant glioma	0.0027	0.0312	CbGpPWpGaD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—POR—malignant glioma	0.00253	0.0292	CbGpPWpGaD
Protriptyline—SLC6A4—Monoamine Transport—SLC6A3—malignant glioma	0.00237	0.0274	CbGpPWpGaD
Protriptyline—SLC6A4—Serotonin Transporter Activity—IL1B—malignant glioma	0.00227	0.0263	CbGpPWpGaD
Protriptyline—SLC6A2—Amine compound SLC transporters—SLC6A3—malignant glioma	0.00215	0.0248	CbGpPWpGaD
Protriptyline—CYP2D6—Xenobiotics—CYP2B6—malignant glioma	0.00215	0.0248	CbGpPWpGaD
Protriptyline—SLC6A2—Monoamine Transport—SLC6A3—malignant glioma	0.00204	0.0236	CbGpPWpGaD
Protriptyline—CYP2D6—Xenobiotics—CYP2C18—malignant glioma	0.00186	0.0215	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—FTH1—malignant glioma	0.00185	0.0214	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—FTH1—malignant glioma	0.00159	0.0184	CbGpPWpGaD
Protriptyline—ABCB1—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00156	0.0181	CbGpPWpGaD
Protriptyline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00149	0.0172	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	0.00139	0.0161	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—NTRK3—malignant glioma	0.00133	0.0154	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00105	0.0122	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—MYB—malignant glioma	0.000971	0.0112	CbGpPWpGaD
Protriptyline—SLC6A4—Monoamine Transport—IL1B—malignant glioma	0.000968	0.0112	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.000937	0.0108	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	0.000932	0.0108	CbGpPWpGaD
Protriptyline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000891	0.0103	CbGpPWpGaD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00088	0.0102	CbGpPWpGaD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000853	0.00986	CbGpPWpGaD
Protriptyline—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00084	0.00971	CbGpPWpGaD
Protriptyline—SLC6A2—Monoamine Transport—IL1B—malignant glioma	0.000832	0.00962	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—GDNF—malignant glioma	0.000807	0.00933	CbGpPWpGaD
Protriptyline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000773	0.00893	CbGpPWpGaD
Protriptyline—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000763	0.00882	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—SLC5A5—malignant glioma	0.00074	0.00855	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—IL12A—malignant glioma	0.000738	0.00853	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000729	0.00843	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000729	0.00843	CbGpPWpGaD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000723	0.00835	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—SLC6A3—malignant glioma	0.000704	0.00814	CbGpPWpGaD
Protriptyline—SLC6A4—Monoamine Transport—TNF—malignant glioma	0.000702	0.00812	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	0.000694	0.00802	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—PML—malignant glioma	0.000682	0.00789	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—SLC5A5—malignant glioma	0.000636	0.00736	CbGpPWpGaD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000626	0.00724	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—TOP2A—malignant glioma	0.000624	0.00721	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—SLC6A3—malignant glioma	0.000606	0.007	CbGpPWpGaD
Protriptyline—SLC6A2—Monoamine Transport—TNF—malignant glioma	0.000604	0.00698	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000599	0.00693	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—GSTP1—malignant glioma	0.000596	0.00689	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.000576	0.00666	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000557	0.00644	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—HLA-C—malignant glioma	0.000545	0.0063	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000522	0.00604	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—GSTP1—malignant glioma	0.000513	0.00593	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00051	0.00589	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—NTRK1—malignant glioma	0.000485	0.00561	CbGpPWpGaD
Protriptyline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000477	0.00551	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.000476	0.0055	CbGpPWpGaD
Protriptyline—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000475	0.00549	CbGpPWpGaD
Protriptyline—SLC6A4—NRF2 pathway—PDGFB—malignant glioma	0.000471	0.00545	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—IL12B—malignant glioma	0.000464	0.00536	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000446	0.00515	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000438	0.00506	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000434	0.00501	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—NCOR1—malignant glioma	0.000424	0.0049	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00042	0.00486	CbGpPWpGaD
Protriptyline—SLC6A2—NRF2 pathway—PDGFB—malignant glioma	0.000405	0.00468	CbGpPWpGaD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000401	0.00464	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000384	0.00444	CbGpPWpGaD
Protriptyline—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000382	0.00441	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000379	0.00438	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000345	0.00399	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000333	0.00385	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.00033	0.00381	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000328	0.00379	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	0.000325	0.00375	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—HLA-B—malignant glioma	0.000322	0.00373	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000318	0.00368	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—PPARG—malignant glioma	0.000304	0.00351	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000302	0.00349	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.000299	0.00345	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000284	0.00328	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000272	0.00315	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000272	0.00314	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000269	0.00311	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000269	0.00311	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000252	0.00292	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CD80—malignant glioma	0.000252	0.00292	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000246	0.00285	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000245	0.00284	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000231	0.00267	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000225	0.0026	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000222	0.00257	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—PTEN—malignant glioma	0.000209	0.00241	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000204	0.00236	CbGpPWpGaD
Protriptyline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000203	0.00235	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—RTEL1—malignant glioma	0.0002	0.00231	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000199	0.0023	CbGpPWpGaD
Protriptyline—SLC6A4—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000198	0.00229	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000196	0.00227	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000194	0.00224	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000191	0.00221	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000191	0.00221	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000189	0.00218	CbGpPWpGaD
Protriptyline—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000187	0.00216	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000185	0.00214	CbGpPWpGaD
Protriptyline—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000184	0.00213	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000178	0.00206	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000178	0.00206	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000177	0.00205	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000177	0.00205	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000176	0.00204	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000174	0.00201	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00016	0.00185	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000151	0.00174	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000143	0.00165	CbGpPWpGaD
Protriptyline—SLC6A4—Circadian rythm related genes—TP53—malignant glioma	0.000142	0.00165	CbGpPWpGaD
Protriptyline—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000129	0.00149	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000128	0.00148	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000124	0.00144	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000123	0.00142	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—COX8A—malignant glioma	0.000115	0.00133	CbGpPWpGaD
Protriptyline—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000111	0.00128	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—COX8A—malignant glioma	0.000108	0.00125	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000105	0.00121	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	9.93e-05	0.00115	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	9.78e-05	0.00113	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—ASMT—malignant glioma	9.78e-05	0.00113	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	9.77e-05	0.00113	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	9.75e-05	0.00113	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	9.65e-05	0.00112	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	9.43e-05	0.00109	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—ASMT—malignant glioma	9.21e-05	0.00106	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—BCAN—malignant glioma	9.19e-05	0.00106	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	8.97e-05	0.00104	CbGpPWpGaD
Protriptyline—SLC6A2—Transmembrane transport of small molecules—RAF1—malignant glioma	8.79e-05	0.00102	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	8.76e-05	0.00101	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—BCAN—malignant glioma	8.66e-05	0.001	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	8.54e-05	0.000987	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	8.23e-05	0.000951	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	7.43e-05	0.000859	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—IDH2—malignant glioma	7.41e-05	0.000856	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—IDH2—malignant glioma	6.98e-05	0.000807	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CYP2B6—malignant glioma	6.97e-05	0.000805	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	6.84e-05	0.00079	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	6.69e-05	0.000773	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CYP2B6—malignant glioma	6.56e-05	0.000759	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—IDH1—malignant glioma	6.37e-05	0.000736	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	6.37e-05	0.000736	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	6.32e-05	0.00073	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—SPHK1—malignant glioma	6.16e-05	0.000713	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CYP2C18—malignant glioma	6.04e-05	0.000698	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—IDH1—malignant glioma	6e-05	0.000694	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—SPHK1—malignant glioma	5.81e-05	0.000672	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	5.8e-05	0.000671	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CYP2C18—malignant glioma	5.69e-05	0.000658	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.61e-05	0.000649	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GSTT1—malignant glioma	4.88e-05	0.000565	CbGpPWpGaD
Protriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	4.74e-05	0.000548	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GSTT1—malignant glioma	4.6e-05	0.000532	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PTGS1—malignant glioma	4.58e-05	0.000529	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PTGS1—malignant glioma	4.31e-05	0.000499	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—BCHE—malignant glioma	4.26e-05	0.000492	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—SLC5A5—malignant glioma	4.2e-05	0.000486	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—BCHE—malignant glioma	4.01e-05	0.000464	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—SLC5A5—malignant glioma	3.96e-05	0.000458	CbGpPWpGaD
Protriptyline—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.87e-05	0.000447	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—GSTP1—malignant glioma	3.39e-05	0.000391	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CAT—malignant glioma	3.29e-05	0.000381	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—GSTP1—malignant glioma	3.19e-05	0.000369	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—NCOR1—malignant glioma	3.11e-05	0.00036	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CAT—malignant glioma	3.1e-05	0.000359	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—NCOR1—malignant glioma	2.93e-05	0.000339	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—CAV1—malignant glioma	2.54e-05	0.000293	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—CAV1—malignant glioma	2.39e-05	0.000276	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PIK3CG—malignant glioma	2.31e-05	0.000267	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PPARG—malignant glioma	2.23e-05	0.000258	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.18e-05	0.000252	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PPARG—malignant glioma	2.1e-05	0.000243	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PIK3CD—malignant glioma	2.03e-05	0.000235	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.91e-05	0.000221	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PIK3CB—malignant glioma	1.77e-05	0.000205	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PTGS2—malignant glioma	1.75e-05	0.000203	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.67e-05	0.000193	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PTGS2—malignant glioma	1.65e-05	0.000191	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PTEN—malignant glioma	1.53e-05	0.000177	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PTEN—malignant glioma	1.44e-05	0.000167	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—PIK3CA—malignant glioma	1.08e-05	0.000125	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.02e-05	0.000118	CbGpPWpGaD
Protriptyline—ABCB1—Metabolism—AKT1—malignant glioma	8.82e-06	0.000102	CbGpPWpGaD
Protriptyline—CYP2D6—Metabolism—AKT1—malignant glioma	8.31e-06	9.6e-05	CbGpPWpGaD
